vVardis Pursues $229 Million US Listing With Apollo Backing

Apollo-backed dental company vVardis is looking to raise as much as $229 million through a US initial public offering, according to the company's disclosed plans. The move would take the dental firm into public markets while retaining the backing of its private equity sponsor.

The offering comes as select private-equity-backed healthcare and consumer companies test investor appetite for new listings. A successful float could give vVardis capital for operations and growth initiatives, while also providing a public currency for future expansion. The planned listing would give the company access to public capital and a broader investor base.

Apollo's involvement may be a key consideration for IPO investors. Sponsorship by a large private equity firm can signal governance and operational support, but it can also focus attention on post-listing ownership, lock-up arrangements and eventual share sales. Those factors often shape pricing and demand for sponsor-backed offerings.

For the wider IPO market, vVardis' pursuit of up to $229 million adds to a pipeline of healthcare-related listings seeking buyer interest. Investors will weigh the company's dental-sector positioning against broader market conditions as the offering moves forward.